MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$962,511
EPS
-$0.53
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-09-30
Accounting and audit fees
108,398
-164,158*
145,579
Research and development
109,925
82,209*
273,229
Legal fees
75,981
508,791*
121,868
Consulting fees
284,542
1,033,422.75*
73,243
Salaries and wages
217,409
-255,442*
340,030
General and administrative - other
97,980
-147,352*
159,915
Stock compensation
67,012
104,647.25*
-
Total operating expenses
961,247
1,162,118
1,113,864
Loss from operations
-961,247
-1,162,118*
-1,113,864
Interest income (expense)
10,763
-1,598,018*
34,337
Derivative expense
-
-85,849.75*
-
Change in fair value of derivative liabilities
-
897,807*
203,354
Foreign currency exchange differences
205
-10,748*
6,677
Gain/loss on disposal of subsidiary
-
6,117,325*
-
Gain/loss on extinguishment of debt
-
-279,444.5*
-
Impairment of intangible assets
13,337
-
-
Total other expenses
-2,369
5,041,071.75*
244,368
Loss before income taxes
-963,616
3,878,953.75
-869,496
Net loss
-963,616
3,878,953.75*
-869,496
Unrealized foreign currency translation gain (loss)
1,105
-313,305*
37,072
Shares issued in connection with phytanix bio purchase
-
-32,503.75*
-
Comprehensive loss
-962,511
3,533,145
-832,424
Basic EPS
-0.53
1.258
-0.47
Diluted EPS
-0.53
1.258
-0.47
Basic Average Shares
1,810,208
2,808,605
1,849,389
Diluted Average Shares
1,810,208
2,808,605
1,849,389
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$962,511 Unrealized foreigncurrency translation...$1,105 Net loss-$963,616 Loss before incometaxes-$963,616 Loss from operations-$961,247 Total other expenses-$2,369 Interest income(expense)$10,763 Foreign currencyexchange differences$205 Total operatingexpenses$961,247 Impairment of intangibleassets$13,337 Consulting fees$284,542 Salaries and wages$217,409 Research and development$109,925 Accounting and audit fees$108,398 General andadministrative - other$97,980 Legal fees$75,981 Stock compensation$67,012

Protagenic Therapeutics, Inc. new (PTIX)

Protagenic Therapeutics, Inc. new (PTIX)